An Overview on Hyperlipidemia

D. A. Helen Sheeba *

Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Science, Vels Institute of Science, Technology and Advanced studies (VISTAS), Pallavaram, Chennai-600 177, Tamil Nadu, India.

R. Gandhimathi

Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Science, Vels Institute of Science, Technology and Advanced studies (VISTAS), Pallavaram, Chennai-600 177, Tamil Nadu, India.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Hyperlipidemia is a medical condition indicated by an increase in one or more plasma lipids, such as triglycerides, cholesterol, cholesterol esters, phospholipids, and/or plasma lipoproteins, such as very low-density lipoprotein and low-density lipoprotein, as well as decreased levels of high-density lipoprotein. This increase in plasma lipids is one of the most important risk factors for cardiovascular disease. In the meanwhile, statins and fibrates remain the most common anti-hyperlipidemic drugs for treating high plasma cholesterol and triglycerides.

Conclusion: Hence this review focused to study of hyperlipidemia. This review is useful to research work in hyperlididemia.

Keywords: hyperlipidemia, lipid transport, cholesterol, dietary plant fibers, hypolipidemic drugs


How to Cite

Sheeba, D. A. Helen, and R. Gandhimathi. 2021. “An Overview on Hyperlipidemia”. Journal of Pharmaceutical Research International 33 (59B):543-55. https://doi.org/10.9734/jpri/2021/v33i59B34413.

Downloads

Download data is not yet available.